http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102245180-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4d4a276b0b56fbeb4a17ab22ccabc35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14ff914f259bb631f31d4b32b1eaddd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db0d729ab897a31facefef0673d8ad4e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01045
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
filingDate 2009-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f19f37329c60790c73028c1c489ef590
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dd9d18d1fd9817ac2d2e1adfca0b473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3296601f634cd8259c5474ddf28acbd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_656ed5407255f8cc6d9d61e25af84a8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3479cae8a792c57b0c7d38419f2d74fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2554038d15be6e4cf8dafa34de951ae
publicationDate 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102245180-A
titleOfInvention Compositions and methods for treating altered alpha-synuclein function
abstract Compositions and methods for treating diseases characterized by alpha-synuclein dysfunction and/or altered lipid metabolism are provided.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104069263-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108348557-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107823198-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105748460-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018024245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105748460-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108143738-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115417789-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105378-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105796579-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115417789-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10064833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-264534-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017167168-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2715703-C1
priorityDate 2008-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008031831-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002147197-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467041491

Total number of triples: 49.